JPMorgan Funds - Thematics - Genetic Therapies I2 Fonds
66,41
USD
+2,54
USD
+3,98
%
NAV
Werbung
Zu diesem Instrument liegen derzeit keine aktuellen Daten vor.
Top Holdings
| Name | ISIN | Anteil |
|---|---|---|
| Vericel Corp | US92346J1088 | 3,63% |
| Krystal Biotech Inc | US5011471027 | 3,28% |
| Novartis AG Registered Shares | CH0012005267 | 3,21% |
| Gilead Sciences Inc | US3755581036 | 3,19% |
| Bio-Techne Corp | US09073M1045 | 3,16% |
| Vertex Pharmaceuticals Inc | US92532F1003 | 3,14% |
| Alnylam Pharmaceuticals Inc | US02043Q1076 | 3,12% |
| PTC Therapeutics Inc | US69366J2006 | 3,09% |
| Sarepta Therapeutics Inc | US8036071004 | 3,05% |
| Arcellx Inc | US03940C1009 | 2,98% |
| Sonstige | 68,16% |